Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURB

The endocannabinoid enzyme, fatty acid amide hydrolase (FAAH), has been proposed as a therapeutic target for alcohol use disorder (AUD) and co-morbid psychiatric illnesses. Investigating this target in the living human brain and its relationship to clinical outcome is a critical step of informed dru...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neuropsychopharmacology
Huvudupphovsmän: Best, Laura M., Williams, Belinda, Le Foll, Bernard, Mansouri, Esmaeil, Bazinet, Richard P., Lin, Lin, De Luca, Vincenzo, Lagzdins, Dina, Rusjan, Pablo, Tyndale, Rachel F., Wilson, Alan A., Hendershot, Christian S., Heilig, Markus, Houle, Sylvain, Tong, Junchao, Kish, Stephen J., Boileau, Isabelle
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer International Publishing 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7298050/
https://ncbi.nlm.nih.gov/pubmed/31910433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-020-0606-2
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk